BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen R, Hou W, Zhang Q, Kang R, Fan XG, Tang D. Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med. 2013;19:357-366. [PMID: 24306421 DOI: 10.2119/molmed.2013.00099] [Cited by in Crossref: 50] [Cited by in F6Publishing: 62] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Sun X, Tang D. HMGB1-dependent and -independent autophagy. Autophagy 2014;10:1873-6. [PMID: 25126737 DOI: 10.4161/auto.32184] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
2 Satoh M, Taira K, Hara T, Siba J, Takeuchi M. High mobility group box 1 can be used to monitor perioperative course in patients with liver cancer. Surg Oncol 2020;33:216-21. [PMID: 31443921 DOI: 10.1016/j.suronc.2019.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chen Q, Zhang Y, Yue ZD, Zhao HW, Wang L, Fan ZH, Liu FQ. High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. J Hepatobiliary Pancreat Sci 2020;27:522-30. [PMID: 32463549 DOI: 10.1002/jhbp.770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Fu S, Wang J, Hu X, Zhou RR, Fu Y, Tang D, Kang R, Huang Y, Sun L, Li N, Fan XG. Crosstalk between hepatitis B virus X and high-mobility group box 1 facilitates autophagy in hepatocytes. Mol Oncol. 2018;12:322-338. [PMID: 29316268 DOI: 10.1002/1878-0261.12165] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
5 Morita A, Omoya Y, Ito R, Ishibashi Y, Hiramoto K, Ohnishi S, Yoshikawa N, Kawanishi S. Glycyrrhizin and its derivatives promote hepatic differentiation via sweet receptor, Wnt, and Notch signaling. Biochem Biophys Rep 2021;28:101181. [PMID: 34934826 DOI: 10.1016/j.bbrep.2021.101181] [Reference Citation Analysis]
6 Borlak J, Länger F, Spanel R, Schöndorfer G, Dittrich C. Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors. Oncotarget 2016;7:28059-74. [PMID: 27058902 DOI: 10.18632/oncotarget.8574] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
7 Liu Z, Xu Y, Long J, Guo K, Ge C, Du R. microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1. Chin J Cancer Res 2015;27:247-57. [PMID: 26157321 DOI: 10.3978/j.issn.1000-9604.2015.04.07] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
8 Hua S, Ma M, Fei X, Zhang Y, Gong F, Fang M. Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis. Int Immunopharmacol 2019;68:145-55. [PMID: 30634142 DOI: 10.1016/j.intimp.2019.01.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
9 Magdaleno F, Blajszczak CC, Nieto N. Key Events Participating in the Pathogenesis of  Alcoholic Liver Disease. Biomolecules 2017;7:E9. [PMID: 28134813 DOI: 10.3390/biom7010009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 6.2] [Reference Citation Analysis]
10 Ge X, Arriazu E, Magdaleno F, Antoine DJ, Dela Cruz R, Theise N, Nieto N. High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice. Hepatology 2018;68:2380-404. [PMID: 29774570 DOI: 10.1002/hep.30093] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
11 Ding J, Cui X, Liu Q. Emerging role of HMGB1 in lung diseases: Friend or foe. J Cell Mol Med. 2017;21:1046-1057. [PMID: 28039939 DOI: 10.1111/jcmm.13048] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
12 Chen S, Yu G, Xie J, Tang W, Gao L, Long X, Ren L, Xie X, Deng Y, Fu Z, Liu E. High-mobility group box-1 protein from CC10+ club cells promotes type 2 response in the later stage of respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2019;316:L280-90. [PMID: 30407867 DOI: 10.1152/ajplung.00552.2017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
13 Bijnen M, Beelen N, Wetzels S, Gaar JV, Vroomen M, Wijnands E, Scheijen JL, van de Waarenburg MPH, Gijbels MJ, Cleutjens JP, Biessen EAL, Stehouwer CDA, Schalkwijk CG, Wouters K. RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr-/- mice. Sci Rep 2018;8:15256. [PMID: 30323247 DOI: 10.1038/s41598-018-33661-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
14 Zeidan E, Li S, Zhou Z, Miller J, Sandros MG. Single-Multiplex Detection of Organ Injury Biomarkers using SPRi based Nano-Immunosensor. Sci Rep 2016;6:36348. [PMID: 27796342 DOI: 10.1038/srep36348] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
15 Yu LX, Ling Y, Wang HY. Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ Precis Oncol 2018;2:6. [PMID: 29872724 DOI: 10.1038/s41698-018-0048-z] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 18.8] [Reference Citation Analysis]
16 Xiao Y, Sun L, Fu Y, Huang Y, Zhou R, Hu X, Zhou P, Quan J, Li N, Fan XG. High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo. BMC Cancer. 2017;17:857. [PMID: 29246127 DOI: 10.1186/s12885-017-3868-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
17 Viswanathan P, Kapoor S, Kumaran V, Joseph B, Gupta S. Etanercept blocks inflammatory responses orchestrated by TNF-α to promote transplanted cell engraftment and proliferation in rat liver. Hepatology. 2014;60:1378-1388. [PMID: 24844924 DOI: 10.1002/hep.27232] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
18 Francque SM, van der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. J Hepatol. 2016;65:425-443. [PMID: 27091791 DOI: 10.1016/j.jhep.2016.04.005] [Cited by in Crossref: 190] [Cited by in F6Publishing: 185] [Article Influence: 31.7] [Reference Citation Analysis]
19 Lee WJ, Song SY, Roh H, Ahn HM, Na Y, Kim J, Lee JH, Yun CO. Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues. Sci Rep 2018;8:8434. [PMID: 29849053 DOI: 10.1038/s41598-018-26501-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
20 Chen X, Zhao HX, Bai C, Zhou XY. Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis. Sci Rep. 2017;7:6799. [PMID: 28754974 DOI: 10.1038/s41598-017-07094-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
21 Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D. HMGB1 in health and disease. Mol Aspects Med 2014;40:1-116. [PMID: 25010388 DOI: 10.1016/j.mam.2014.05.001] [Cited by in Crossref: 445] [Cited by in F6Publishing: 443] [Article Influence: 55.6] [Reference Citation Analysis]
22 Wang L, Li X, Chen C. Inhibition of acetaminophen-induced hepatotoxicity in mice by exogenous thymosinβ4 treatment. Int Immunopharmacol 2018;61:20-8. [PMID: 29793165 DOI: 10.1016/j.intimp.2018.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
23 Ni YA, Chen H, Nie H, Zheng B, Gong Q. HMGB1: An overview of its roles in the pathogenesis of liver disease. J Leukoc Biol 2021. [PMID: 33784425 DOI: 10.1002/JLB.3MR0121-277R] [Reference Citation Analysis]
24 Wang Y, Xiao X, Wang F, Yang Z, Yue J, Shi J, Ke F, Xie Z, Fan Y. An identified PfHMGB1 promotes microcystin-LR-induced liver injury of yellow catfish (Pelteobagrus fulvidraco). Ecotoxicol Environ Saf 2021;207:111266. [PMID: 32919194 DOI: 10.1016/j.ecoenv.2020.111266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Lan J, Luo H, Wu R, Wang J, Zhou B, Zhang Y, Jiang Y, Xu J. Internalization of HMGB1 (High Mobility Group Box 1) Promotes Angiogenesis in Endothelial Cells. Arterioscler Thromb Vasc Biol 2020;40:2922-40. [PMID: 32998518 DOI: 10.1161/ATVBAHA.120.315151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Kuwano A, Kohjima M, Suzuki H, Yamasaki A, Ohashi T, Imoto K, Kurokawa M, Morita Y, Kato M, Ogawa Y. Recombinant human soluble thrombomodulin ameliorates acetaminophen-induced liver toxicity in mice. Exp Ther Med 2019;18:1323-30. [PMID: 31316624 DOI: 10.3892/etm.2019.7665] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Huang F, Wang BR, Wang YG. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World J Gastroenterol 2018; 24(41): 4643-4651 [PMID: 30416312 DOI: 10.3748/wjg.v24.i41.4643] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 72] [Article Influence: 18.5] [Reference Citation Analysis]
28 Kim KE, Ko KH, Heo RW, Yi CO, Shin HJ, Kim JY, Park JH, Nam S, Kim H, Roh GS. Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice. J Med Food. 2016;19:290-299. [PMID: 26741655 DOI: 10.1089/jmf.2015.3527] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
29 Jiang L, Ke M, Yue S, Xiao W, Yan Y, Deng X, Ying QL, Li J, Ke B. Blockade of Notch signaling promotes acetaminophen-induced liver injury. Immunol Res 2017;65:739-49. [PMID: 28286920 DOI: 10.1007/s12026-017-8913-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
30 Albadawy R, Agwa SHA, Khairy E, Saad M, El Touchy N, Othman M, El Kassas M, Matboli M. Circulatory Endothelin 1-Regulating RNAs Panel: Promising Biomarkers for Non-Invasive NAFLD/NASH Diagnosis and Stratification: Clinical and Molecular Pilot Study. Genes (Basel) 2021;12:1813. [PMID: 34828420 DOI: 10.3390/genes12111813] [Reference Citation Analysis]
31 Lin M, Long J, Li W, Yang C, Loughran P, O'Doherty R, Billiar TR, Deng M, Scott MJ. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding. Mol Med 2020;26:115. [PMID: 33238880 DOI: 10.1186/s10020-020-00227-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Shan Z, Ju C. Hepatic Macrophages in Liver Injury. Front Immunol 2020;11:322. [PMID: 32362892 DOI: 10.3389/fimmu.2020.00322] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
33 Ge S, Xiong Y, Wu X, Xie J, Liu F, He J, Xiang T, Cheng N, Lai L, Zhong Y. Role of growth factor receptor-bound 2 in CCl4-induced hepatic fibrosis. Biomed Pharmacother 2017;92:942-51. [PMID: 28618656 DOI: 10.1016/j.biopha.2017.05.142] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
34 Xie L, Huang Y. Antagonism of RIP1 using necrostatin-1 (Nec-1) ameliorated damage and inflammation of HBV X protein (HBx) in human normal hepatocytes. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:1194-9. [DOI: 10.1080/21691401.2019.1575231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Qi J, Elson DS. Mueller polarimetric imaging for surgical and diagnostic applications: a review. J Biophotonics 2017;10:950-82. [PMID: 28464464 DOI: 10.1002/jbio.201600152] [Cited by in Crossref: 69] [Cited by in F6Publishing: 41] [Article Influence: 13.8] [Reference Citation Analysis]
36 Ignat SR, Dinescu S, Hermenean A, Costache M. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development. Cells 2020;9:E461. [PMID: 32085494 DOI: 10.3390/cells9020461] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
37 Capuani B, Della-Morte D, Donadel G, Caratelli S, Bova L, Pastore D, De Canio M, D'Aguanno S, Coppola A, Pacifici F, Arriga R, Bellia A, Ferrelli F, Tesauro M, Federici M, Neri A, Bernardini S, Sbraccia P, Di Daniele N, Sconocchia G, Orlandi A, Urbani A, Lauro D. Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology. Am J Physiol Endocrinol Metab 2015;308:E744-55. [PMID: 25714671 DOI: 10.1152/ajpendo.00447.2014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
38 Krishnasamy Y, Ramshesh VK, Gooz M, Schnellmann RG, Lemasters JJ, Zhong Z. Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice. PLoS One 2016;11:e0163342. [PMID: 27676640 DOI: 10.1371/journal.pone.0163342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
39 Zhao P, Ye T, Yan X, Hu X, Liu P, Wang X. HMGB1 release by H2O2-induced hepatocytes is regulated through calcium overload and 58-F interference. Cell Death Discov. 2017;3:17008. [PMID: 28417016 DOI: 10.1038/cddiscovery.2017.8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
40 Alhasson F, Dattaroy D, Das S, Chandrashekaran V, Seth RK, Schnellmann RG, Chatterjee S. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity. Am J Physiol Renal Physiol 2016;310:F85-F101. [PMID: 26447219 DOI: 10.1152/ajprenal.00243.2015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
41 Xu H, Wandersee NJ, Guo Y, Jones DW, Holzhauer SL, Hanson MS, Machogu E, Brousseau DC, Hogg N, Densmore JC, Kaul S, Hillery CA, Pritchard KA Jr. Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation. Blood 2014;124:3978-81. [PMID: 25339362 DOI: 10.1182/blood-2014-04-560813] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
42 Tripisciano C, Eichhorn T, Harm S, Weber V. Adsorption of the inflammatory mediator high-mobility group box 1 by polymers with different charge and porosity. Biomed Res Int 2014;2014:238160. [PMID: 25243124 DOI: 10.1155/2014/238160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
43 Meakin PJ, Chowdhry S, Sharma RS, Ashford FB, Walsh SV, McCrimmon RJ, Dinkova-Kostova AT, Dillon JF, Hayes JD, Ashford ML. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol Cell Biol. 2014;34:3305-3320. [PMID: 24958099 DOI: 10.1128/mcb.00677-14] [Cited by in Crossref: 119] [Cited by in F6Publishing: 63] [Article Influence: 14.9] [Reference Citation Analysis]
44 Wang Y, Yang Y, Chen Q, Zhai H, Xie Z, Ke F. PfHMGB2 protects yellow catfish (Pelteobagrus fulvidraco) from bacterial infection by promoting phagocytosis and proliferation of PBL. Fish Shellfish Immunol 2019;93:567-74. [PMID: 31394161 DOI: 10.1016/j.fsi.2019.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
45 Zhou RR, Kuang XY, Huang Y, Li N, Zou MX, Tang DL, Fan XG. Potential role of High mobility group box 1 in hepatocellular carcinoma. Cell Adh Migr 2014;8:493-8. [PMID: 25482616 DOI: 10.4161/19336918.2014.969139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
46 Stojek M, Adrych K, Rojek L, Smoczynski M, Sledzinski T, Szrok S, Swierczynski J. Decreased serum platelet derived growth factor BB levels in acute and increased in chronic pancreatitis. World J Gastroenterol 2014; 20(36): 13127-13132 [PMID: 25278706 DOI: 10.3748/wjg.v20.i36.13127] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
47 de Oliveira Gomes CG, de Andrade MVM, Guedes LR, Rocha HC, Guimarães RG, Carvalho FAC, Vilela EG. Evaluation of the Biomarkers HMGB1 and IL-6 as Predictors of Mortality in Cirrhotic Patients with Acute Kidney Injury. Mediators Inflamm 2020;2020:2867241. [PMID: 33061824 DOI: 10.1155/2020/2867241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Lu H, Ye C, Feng X, Liu J, Bhaumik M, Xia B, Liu C, Shen Z. Spontaneous Development of Hepatocellular Carcinoma and B-Cell Lymphoma in Mosaic and Heterozygous Brca2 and Cdkn1a Interacting Protein Knockout Mice. Am J Pathol 2020;190:1175-87. [PMID: 32201259 DOI: 10.1016/j.ajpath.2020.01.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
49 Gibert-Ramos A, Sanfeliu-Redondo D, Aristu-Zabalza P, Martínez-Alcocer A, Gracia-Sancho J, Guixé-Muntet S, Fernández-Iglesias A. The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer. Cancers (Basel) 2021;13:5719. [PMID: 34830874 DOI: 10.3390/cancers13225719] [Reference Citation Analysis]
50 Evangelakos I, Heeren J, Verkade E, Kuipers F. Role of bile acids in inflammatory liver diseases. Semin Immunopathol 2021. [PMID: 34236487 DOI: 10.1007/s00281-021-00869-6] [Reference Citation Analysis]
51 Rao Y, Su J, Yang C, Yan N, Chen X, Feng X. Dynamic localization and the associated translocation mechanism of HMGBs in response to GCRV challenge in CIK cells. Cell Mol Immunol 2015;12:342-53. [PMID: 25042634 DOI: 10.1038/cmi.2014.55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
52 Ding JW, Zheng XX, Zhou T, Tong XH, Luo CY, Wang XA. HMGB1Modulates the Treg/Th17 Ratio in Atherosclerotic Patients. J Atheroscler Thromb 2016;23:737-45. [PMID: 26830200 DOI: 10.5551/jat.31088] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
53 Dos Santos Pinheiro C, de Oliveira Gomes CG, Ribeiro Lima Machado C, Guedes LR, Rocha HC, Guimarães RG, Carvalho FAC, Saturnino SF, do Nascimento VC, de Andrade MVM, Vilela EG. Performance of High Mobility Protein Group 1 and Interleukin-6 as Predictors of Outcomes Resulting from Variceal Bleeding in Patients with Advanced Chronic Liver Disease. Inflammation 2021. [PMID: 34618276 DOI: 10.1007/s10753-021-01565-1] [Reference Citation Analysis]
54 Zhang Y, Wang G, Zhu WC, Chen Z. Changes in expression of high mobility group protein B1 in acute liver failure in rats. Shijie Huaren Xiaohua Zazhi 2015; 23(9): 1402-1410 [DOI: 10.11569/wcjd.v23.i9.1402] [Reference Citation Analysis]
55 Sun X, Tang D. Hepatocyte-specific Hmgb1 Deletion. Autophagy 2015;11:1189-91. [PMID: 26043873 DOI: 10.1080/15548627.2015.1054595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
56 Zhang W, Lavine KJ, Epelman S, Evans SA, Weinheimer CJ, Barger PM, Mann DL. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J Am Heart Assoc 2015;4:e001993. [PMID: 26037082 DOI: 10.1161/JAHA.115.001993] [Cited by in Crossref: 83] [Cited by in F6Publishing: 58] [Article Influence: 11.9] [Reference Citation Analysis]
57 Zeng W, Shan W, Gao L, Gao D, Hu Y, Wang G, Zhang N, Li Z, Tian X, Xu W. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Sci Rep. 2015;5:16013. [PMID: 26525891 DOI: 10.1038/srep16013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 8.6] [Reference Citation Analysis]
58 Lundbäck P, Stridh P, Klevenvall L, Jenkins RE, Fischer M, Sundberg E, Andersson U, Antoine DJ, Harris HE. Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis. Antioxid Redox Signal 2016;24:605-19. [PMID: 25532033 DOI: 10.1089/ars.2014.6039] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
59 Otabe H, Nibuya M, Shimazaki K, Toda H, Suzuki G, Nomura S, Shimizu K. Electroconvulsive seizures enhance autophagy signaling in rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2014;50:37-43. [DOI: 10.1016/j.pnpbp.2013.11.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
60 Kim SJ, Lee SM. Necrostatin-1 Protects Against D-Galactosamine and Lipopolysaccharide-Induced Hepatic Injury by Preventing TLR4 and RAGE Signaling. Inflammation 2017;40:1912-23. [PMID: 28752362 DOI: 10.1007/s10753-017-0632-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
61 Bai L, Kong M, Zheng Q, Zhang X, Liu X, Zu K, Chen Y, Zheng S, Li J, Ren F, Lou J, Liu S, Duan Z. Inhibition of the translocation and extracellular release of high-mobility group box 1 alleviates liver damage in fibrotic mice in response to D-galactosamine/lipopolysaccharide challenge. Mol Med Rep 2016;13:3835-41. [PMID: 27035642 DOI: 10.3892/mmr.2016.5003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
62 Ferrero-Andrés A, Panisello-Roselló A, Roselló-Catafau J, Folch-Puy E. NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis. Int J Mol Sci 2020;21:E5386. [PMID: 32751171 DOI: 10.3390/ijms21155386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Miyata N, Yoshimura Y, Hikosaka K, Norose K, Tachikawa N. Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments. J Infect Chemother 2020;26:289-93. [PMID: 31711832 DOI: 10.1016/j.jiac.2019.10.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Chen R, Xie Y, Zhong X, Fu Y, Huang Y, Zhen Y, Pan P, Wang H, Bartlett DL, Billiar TR, Lotze MT, Zeh HJ 3rd, Fan XG, Tang D, Kang R. Novel chemokine-like activities of histones in tumor metastasis. Oncotarget 2016;7:61728-40. [PMID: 27623211 DOI: 10.18632/oncotarget.11226] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
65 Li F, Huangyang P, Burrows M, Guo K, Riscal R, Godfrey J, Lee KE, Lin N, Lee P, Blair IA, Keith B, Li B, Simon MC. FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nat Cell Biol 2020;22:728-39. [PMID: 32367049 DOI: 10.1038/s41556-020-0511-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
66 Liu Y, Zhuang GB, Zhou XZ. HMBG1 as a Driver of Inflammatory and Immune Processes in the Pathogenesis of Ocular Diseases. J Ophthalmol 2018;2018:5195290. [PMID: 30473885 DOI: 10.1155/2018/5195290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]